Breakthrough pain: the importance of baseline analgesic regimen with opioids

about

Prevalence and characteristics of breakthrough cancer pain in an outpatient clinic in a Catalan teaching hospital: incorporation of the Edmonton Classification System for Cancer pain into the diagnostic algorithm.

P2860

Q55165284-23733E01-7AF4-4C66-AFF5-66A9F8BF5E2D

P2860

Breakthrough pain: the importance of baseline analgesic regimen with opioids

Item

http://www.wikidata.org/entity/Q41880809

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Breakthrough pain: the importance of baseline analgesic regimen with opioids

@en

type

Item

label

Breakthrough pain: the importance of baseline analgesic regimen with opioids

@en

prefLabel

Breakthrough pain: the importance of baseline analgesic regimen with opioids

@en

P1476

Breakthrough pain: the importance of baseline analgesic regimen with opioids

@en

P2093

Annamaria Vinciguerra

http://www.w3.org/2001/XMLSchema#string

Antonietta Morabito

http://www.w3.org/2001/XMLSchema#string

Fabiana Salvato

http://www.w3.org/2001/XMLSchema#string

Maddalena Zampi

http://www.w3.org/2001/XMLSchema#string

P2860

Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process

A role of RGS proteins in drug addiction

Opioid-induced hyperalgesia: a qualitative systematic review

Codeine intoxication associated with ultrarapid CYP2D6 metabolism

Incomplete cross tolerance and multiple mu opioid peptide receptors.

Opioids for cancer pain: the challenge of optimizing treatment.

How to design an opioid drug that causes reduced tolerance and dependence.

3-Methoxynaltrexone, a selective heroin/morphine-6beta-glucuronide antagonist.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphon

Genetic polymorphisms of the human MDR1 drug transporter.

P304

62-66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23905054

http://www.w3.org/2001/XMLSchema#string

P932

3728788

http://www.w3.org/2001/XMLSchema#string

Breakthrough pain: the importance of baseline analgesic regimen with opioids

about

P2860

P2860

Breakthrough pain: the importance of baseline analgesic regimen with opioids

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P478

P577

P698

P932